Market closedNon-fractional
DarioHealth/DRIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About DarioHealth
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Ticker
DRIO
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
New York, United States
Employees
285
Website
www.dariohealth.com
DarioHealth Metrics
BasicAdvanced
$35M
Market cap
-
P/E ratio
-$1.64
EPS
1.53
Beta
-
Dividend rate
Price and volume
Market cap
$35M
Beta
1.53
Financial strength
Current ratio
2.95
Quick ratio
2.619
Long term debt to equity
32.757
Total debt to equity
39.003
Interest coverage (TTM)
-530.24%
Management effectiveness
Return on assets (TTM)
-31.39%
Return on equity (TTM)
-71.67%
Valuation
Price to revenue (TTM)
1.849
Price to book
0.44
Price to tangible book (TTM)
-11.3
Price to free cash flow (TTM)
-0.896
Growth
Revenue change (TTM)
-28.58%
Earnings per share change (TTM)
-24.71%
3-year revenue growth (CAGR)
26.07%
3-year earnings per share growth (CAGR)
-22.00%
What the Analysts think about DarioHealth
Analyst Ratings
Majority rating from 3 analysts.
DarioHealth Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$5.7M
58.33%
Net income
-$7.1M
-50.00%
Profit margin
-124.56%
-68.42%
DarioHealth Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.58
-$0.49
-$0.50
-$0.20
-
Expected
-$0.52
-$0.46
-$0.55
-$0.41
-$0.38
Surprise
11.11%
6.52%
-9.64%
-50.62%
-
DarioHealth News
AllArticlesVideos
Dario Expands GLP-1 Solution Client Base with New Employer Contract
PRNewsWire·2 weeks ago
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
PRNewsWire·1 month ago
Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer
PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for DarioHealth stock?
DarioHealth (DRIO) has a market cap of $35M as of July 27, 2024.
What is the P/E ratio for DarioHealth stock?
The price to earnings (P/E) ratio for DarioHealth (DRIO) stock is 0 as of July 27, 2024.
Does DarioHealth stock pay dividends?
No, DarioHealth (DRIO) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next DarioHealth dividend payment date?
DarioHealth (DRIO) stock does not pay dividends to its shareholders.
What is the beta indicator for DarioHealth?
DarioHealth (DRIO) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell DarioHealth stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.